Community Healthcare Analyst Ratings
Community Healthcare Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/17/2023 | 10.86% | Piper Sandler | $41 → $45 | Maintains | Overweight |
| 01/13/2023 | 8.4% | Janney Montgomery Scott | → $44 | Upgrades | Neutral → Buy |
| 10/07/2022 | 1.01% | Piper Sandler | $45 → $41 | Maintains | Overweight |
| 09/27/2022 | 5.94% | Evercore ISI Group | $45 → $43 | Maintains | Outperform |
| 07/11/2022 | 8.4% | Truist Securities | $49 → $44 | Maintains | Buy |
| 11/25/2020 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
| 08/06/2020 | 35.5% | Piper Sandler | $38 → $55 | Maintains | Overweight |
| 06/08/2020 | 5.94% | Evercore ISI Group | → $43 | Downgrades | Outperform → In-Line |
| 05/14/2020 | -6.38% | Piper Sandler | $35 → $38 | Maintains | Overweight |
| 05/07/2020 | -1.45% | B. Riley Securities | → $40 | Downgrades | Buy → Neutral |
| 04/23/2020 | -3.92% | SunTrust Robinson Humphrey | $46 → $39 | Maintains | Buy |
| 03/20/2020 | -1.45% | B. Riley Securities | $47 → $40 | Upgrades | Neutral → Buy |
| 03/06/2020 | 15.79% | B. Riley Securities | $42 → $47 | Maintains | Neutral |
| 02/28/2020 | 28.11% | Baird | $48 → $52 | Maintains | Outperform |
| 11/18/2019 | — | Piper Sandler | Upgrades | Hold → Buy | |
| 11/07/2019 | 3.47% | B. Riley Securities | $38 → $42 | Maintains | Neutral |
| 07/10/2019 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
| 04/23/2019 | — | Berenberg | Initiates Coverage On | → Buy | |
| 04/10/2019 | -1.45% | Baird | → $40 | Initiates Coverage On | → Outperform |
| 03/28/2019 | -6.38% | DA Davidson | → $38 | Initiates Coverage On | → Neutral |
| 11/16/2018 | -95.07% | UBS | → $2 | Initiates Coverage On | → Sell |
| 11/12/2018 | -23.63% | B. Riley Securities | $32 → $31 | Maintains | Neutral |
| 08/13/2018 | -21.16% | B. Riley Securities | $28 → $32 | Maintains | Neutral |
| 05/11/2018 | -31.02% | B. Riley Securities | $27 → $28 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 01/17/2023 | 10.86% | 派珀·桑德勒 | $41 → $45 | 维护 | 超重 |
| 01/13/2023 | 8.4% | 詹尼·蒙哥马利·斯科特 | → $44 | 升级 | 中性→购买 |
| 10/07/2022 | 1.01% | 派珀·桑德勒 | $45 → $41 | 维护 | 超重 |
| 09/27/2022 | 5.94% | Evercore ISI集团 | $45 → $43 | 维护 | 跑赢大盘 |
| 07/11/2022 | 8.4% | Truist证券 | $49 → $44 | 维护 | 买 |
| 11/25/2020 | — | Evercore ISI集团 | 升级 | 线内→表现优异 | |
| 08/06/2020 | 35.5% | 派珀·桑德勒 | $38 → $55 | 维护 | 超重 |
| 06/08/2020 | 5.94% | Evercore ISI集团 | → $43 | 评级下调 | 胜过→同线 |
| 05/14/2020 | -6.38% | 派珀·桑德勒 | $35 → $38 | 维护 | 超重 |
| 05/07/2020 | -1.45% | B.莱利证券 | → $40 | 评级下调 | 购买→中性 |
| 04/23/2020 | -3.92% | SunTrust Robinson Humphrey | $46 → $39 | 维护 | 买 |
| 03/20/2020 | -1.45% | B.莱利证券 | $47 → $40 | 升级 | 中性→购买 |
| 03/06/2020 | 15.79% | B.莱利证券 | $42 → $47 | 维护 | 中性 |
| 02/28/2020 | 28.11% | 贝尔德 | $48 → $52 | 维护 | 跑赢大盘 |
| 11/18/2019 | — | 派珀·桑德勒 | 升级 | 持有→购买 | |
| 11/07/2019 | 3.47% | B.莱利证券 | $38 → $42 | 维护 | 中性 |
| 07/10/2019 | — | 詹尼·蒙哥马利·斯科特 | 评级下调 | 购买→中性 | |
| 04/23/2019 | — | 贝伦伯格 | 开始承保 | →购买 | |
| 04/10/2019 | -1.45% | 贝尔德 | → $40 | 开始承保 | →跑赢大盘 |
| 03/28/2019 | -6.38% | 达·戴维森 | → $38 | 开始承保 | →中性 |
| 11/16/2018 | -95.07% | 瑞银集团 | → $2 | 开始承保 | →销售 |
| 11/12/2018 | -23.63% | B.莱利证券 | $32 → $31 | 维护 | 中性 |
| 08/13/2018 | -21.16% | B.莱利证券 | $28 → $32 | 维护 | 中性 |
| 05/11/2018 | -31.02% | B.莱利证券 | $27 → $28 | 维护 | 中性 |
What is the target price for Community Healthcare (CHCT)?
社区医疗(CHCT)的目标价格是多少？
The latest price target for Community Healthcare (NYSE: CHCT) was reported by Janney Montgomery Scott on January 13, 2023. The analyst firm set a price target for $44.00 expecting CHCT to rise to within 12 months (a possible 8.40% upside). 4 analyst firms have reported ratings in the last year.
Janney Montgomery Scott于2023年1月13日报道了社区医疗保健(NYSE：CHCT)的最新目标价。这家分析公司将目标价定为44.00美元，预计CHCT将在12个月内升至(可能上涨8.40%)。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Community Healthcare (CHCT)?
社区医疗(CHCT)的最新分析师评级是多少？
The latest analyst rating for Community Healthcare (NYSE: CHCT) was provided by Janney Montgomery Scott, and Community Healthcare upgraded their buy rating.
社区医疗(NYSE：CHCT)的最新分析师评级由Janney Montgomery Scott提供，社区医疗上调了买入评级。
When is the next analyst rating going to be posted or updated for Community Healthcare (CHCT)?
社区医疗(CHCT)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Healthcare was filed on January 13, 2023 so you should expect the next rating to be made available sometime around January 13, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与社区医疗保健的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。社区卫生保健的上一次评级是在2023年1月13日提交的，所以你应该预计下一次评级将在2024年1月13日左右的某个时候公布。
Is the Analyst Rating Community Healthcare (CHCT) correct?
分析师对社区医疗保健(CHCT)的评级正确吗？
While ratings are subjective and will change, the latest Community Healthcare (CHCT) rating was a upgraded with a price target of $0.00 to $44.00. The current price Community Healthcare (CHCT) is trading at is $40.59, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的社区医疗保健(CHCT)评级被上调，目标价为0.00美元至44.00美元。目前Community Healthcare(CHCT)的交易价格为40.59美元，在分析师的预测范围内。